“…(Bahadur, Thapa, & Xu, ; B. Cheng et al, ; Cong et al, ; Y. Gao & Dong, ; F. Wu et al, ; Z. Xu, Liu, Kang, & Wang, ). This “intelligent” nanomedicine possesses the properties of programmed site‐specific drug release behavior for improved cancer treatment (R. Cheng, Meng, Deng, Klok, & Zhong, ; Kakwere et al, ; Sokolovskaya, Rahmani, Misra, Brase, & Lahann, ; F. Xu et al, ). The named DOX/Au@Pt‐cRGD nanocarrier showed controlled drug release behavior, which dual trigged by pH and NIR laser (Q. Yang et al, ).…”